Intravenous lignocaine in the management of primary fibromyalgia syndrome.
Ten patients with primary fibromyalgia syndrome were treated with intravenous infusions of lignocaine on a daily basis for six days. This treatment produced a clinically useful improvement in pain relief and mood scores at the time of discharge on day seven and at follow-up on day thirty.
Bennett
M I
MI
West Midlands Regional Pain Relief Unit, Guest and Corbett Hospitals, Dudley, West Midlands, U.K.
Tai
Y M
YM
D000328:Adult; D000368:Aged; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005356:Fibromyalgia / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D007262:Infusions, Intravenous; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010147:Pain Measurement; D012189:Retrospective Studies
D000779:Anesthetics, Local; D008012:Lidocaine